These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17822799)

  • 21. Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China.
    Chen X; Stanton B; Wang X; Nyamette A; Pach A; Kaljee L; Pack R; von Seidlein L; Clemens J; Gong Y; Mao R
    Vaccine; 2006 Jan; 24(5):561-71. PubMed ID: 16159688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.
    Albert MJ; Qadri F; Wahed MA; Ahmed T; Rahman AS; Ahmed F; Bhuiyan NA; Zaman K; Baqui AH; Clemens JD; Black RE
    J Infect Dis; 2003 Mar; 187(6):909-13. PubMed ID: 12660937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage and acceptability of cholera vaccine among high-risk population of urban Dhaka, Bangladesh.
    Uddin MJ; Wahed T; Saha NC; Kaukab SS; Khan IA; Khan AI; Saha A; Chowdhury F; Clemens JD; Qadri F
    Vaccine; 2014 Sep; 32(43):5690-5. PubMed ID: 25149429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
    Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
    J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothetical assessment of efficiency, willingness-to-accept and willingness-to-pay for dengue vaccine and treatment: a contingent valuation survey in Bangladesh.
    Kabir KMA; Hagishima A; Tanimoto J
    Hum Vaccin Immunother; 2021 Mar; 17(3):773-784. PubMed ID: 32820987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.
    Cook J; Jeuland M; Maskery B; Lauria D; Sur D; Clemens J; Whittington D
    J Policy Anal Manage; 2009; 28(1):6-28. PubMed ID: 19090047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to pay for weight-control treatment.
    Liu JT; Tsou MW; Hammitt JK
    Health Policy; 2009 Jul; 91(2):211-8. PubMed ID: 19167128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The private demand for an AIDS vaccine in Thailand.
    Suraratdecha C; Ainsworth M; Tangcharoensathien V; Whittington D
    Health Policy; 2005 Mar; 71(3):271-87. PubMed ID: 15694496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
    Carlsson KS; Höjgård S; Lethagen S; Lindgren A; Berntorp E; Lindgren B
    Haemophilia; 2004 Sep; 10(5):527-41. PubMed ID: 15357780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demand for private health insurance in Chinese urban areas.
    Ying XH; Hu TW; Ren J; Chen W; Xu K; Huang JH
    Health Econ; 2007 Oct; 16(10):1041-50. PubMed ID: 17199233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventions.
    Debes AK; Ali M; Azman AS; Yunus M; Sack DA
    Int J Epidemiol; 2016 Dec; 45(6):2134-2139. PubMed ID: 27789673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
    López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
    Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Households willingness to pay for long-lasting insecticide treated nets in three urban communities of Assosa Zone, western Ethiopia.
    Legesse Y; Tegegn A; Belachew T; Tushune K
    Ethiop Med J; 2007 Oct; 45(4):353-62. PubMed ID: 18326345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stated preferences for the removal of physical pain resulting from permanently disabling occupational injuries. A contingent valuation study of Taiwan.
    Ho JJ; Liu JT; Wang JD
    Accid Anal Prev; 2005 May; 37(3):537-48. PubMed ID: 15784208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community perceptions of bloody diarrhoea in an urban slum in South Asia: implications for introduction of a Shigella vaccine.
    Arvelo W; Blum LS; Nahar N; von Seidlein L; Nahar L; Pack RP; Brooks AW; Pach A; Breiman RF; Luby SP; Ram PK
    Epidemiol Infect; 2011 Apr; 139(4):599-605. PubMed ID: 20546637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coverage of vaccines in private health plans: what does the public prefer?
    Davis MM; Fant K
    Health Aff (Millwood); 2005; 24(3):770-9. PubMed ID: 15886172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.